Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-02-26 @ 12:38 AM
Study NCT ID:
NCT02721732
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-31
First Post:
2016-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Malignant Solid Neoplasm | View |
| None | Carcinoma of Unknown Primary | View |
| None | Metastatic Adrenal Gland Pheochromocytoma | View |
| None | Metastatic Kidney Medullary Carcinoma | View |
| None | Metastatic Malignant Germ Cell Tumor | View |
| None | Metastatic Malignant Solid Neoplasm | View |
| None | Metastatic Paraganglioma | View |
| None | Metastatic Penile Carcinoma | View |
| None | Metastatic Skin Squamous Cell Carcinoma | View |
| None | Small Cell Carcinoma | View |
| None | Stage III Adrenal Cortex Carcinoma AJCC v7 | View |
| None | Stage IV Adrenal Cortex Carcinoma AJCC v7 | View |
| None | Stage IV Penile Cancer AJCC v7 | View |
| None | Stage IV Renal Cell Cancer AJCC v7 | View |
| None | Unresectable Adrenal Gland Pheochromocytoma | View |
| None | Unresectable Paraganglioma | View |
| None | Unresectable Skin Squamous Cell Carcinoma | View |
| None | Unresectable Solid Neoplasm | View |
| None | Vascular Neoplasm | View |
Keywords: